The global cancer/tumor profiling service market size is expected to reach USD 18.13 Billion in 2028 and register a revenue CAGR of 10.3% over the forecast period, according to latest report by Reports and Data. Rapid market revenue growth can be attributed to benefits of cancer/tumor profiling service in cancer treatment. cancer/tumor profiling service facilitates early treatment of patients and discovery of targeted medicine. It also helps in lowering mortality rates and in collecting more data on different types of cancer at various stages.

cancer/tumor profiling service enables doctors to confirm presence of cancer from various proteins, biomarkers, or gene mutations within tissues. This method helps in predicting recurrences of cancer and its spread within the body. Profiling helps oncologists plan treatment in the most effective way to cure this disease.

Growing investments by private players on new technologies and government spending on healthcare are increasing demand for cancer/tumor profiling service.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4839

Some Key Factors Contributing to the Global Pharma & Healthcare Market Growth

Unprecedented revenue growth of the global pharma & healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health & wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in R&D activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Some Key Highlights from the Report

  • By cancer type, lung cancer segment revenue is expected to grow at a faster rate over the forecast period. Increasing cases of lung cancer have been observed across the globe. cancer/tumor profiling service for lung cancer is of utmost importance as a decent number of biomarkers have been recognized, and so this cancer can be treated with targeted medicine.
  • Biomarkers are those biological molecules that are used to detect presence of any abnormality in cells in the human body. It is generally found in blood, other body fluids, or tissues. cancer/tumor profiling service technologies help in identifying these biomarkers at the earliest and thereby helps in reducing mortality rates.
  • By technology, next-generation sequencing (NGS) segment accounted for largest revenue share in 2020. This technology is known for its ultra-high output, scalability, and speed. A deep study of genetically mutated regions and rapid sequencing of whole genomes are key functionalities of NGS in cancer/tumor profiling service.
  • The cancer/tumor profiling service market in North America accounted for largest revenue share in 2020, due to growing initiatives by governments to promote innovation in the oncology field and rising cases of metastatic cancer in the region. Additionally, presence of various major players such as Illumina Inc. and Thermo Fisher Scientific Inc. in the region is boosting revenue growth of the market in this region.
  • In November 2021, Thermo Fisher Scientific Inc. received approval from FDA for the device named QuantStudio-7 Pro Dx Real-Time PCR System as a class II medical device. This device is known for fast ramp-up with no specialized training and various other in-built technologies to support productivity.

Top Players in the Global Cancer and Tumor Profiling Market:

Thermo Fisher Scientific Inc., Illumina Inc., Siemens AG, F.Hoffmann La Roche Ltd, Nanostring Technologies Inc., BioGenex, Neogenomics Laboratories Inc., HTG Molecular Diagnostics Inc., Perkin Elmer Inc, CellCarta Inc, Ribomed Biotechnologies Inc, Perthera, Qiagen N.V., and Personalis Inc.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma & healthcare industry revenue growth over the recent past.  

To know more about the report @ https://www.reportsanddata.com/report-detail/cancer-and-tumor-profiling-market

Cancer and Tumor Profiling Market Segmentation:

Cancer Type Outlook (Revenue, USD Billion; 2018–2028)

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma
  • Ovarian Cancer
  • Stomach Cancer
  • Pancreatic Cancer
  • Thyroid Cancer
  • Sarcoid
  • Other

Technology Outlook (Revenue, USD Billion; 2018–2028)

  • Immunohistochemistry(IHC)
  • Fluorescence in situ Hybridization (FISH)
  • Next-Generation Sequencing (NGS)
  • Quantitative Polymerase Chain Reaction (qPCR)
  • Chromogenic in Situ Hybridization (CISH)
  • Microarray
  • Others

Biomarker Type Outlook (Revenue, USD Billion; 2018–2028)

  • Genetic
  • Protein
  • Others

Process Type Outlook (Revenue, USD Billion; 2018–2028)

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics
  • Others

Application Outlook (Revenue, USD Billion; 2018–2028)

  • Research
  • Clinical
  • Machine learning

Global Cancer and Tumor Profiling Market Report: Regional Segmentation

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • A.E.
    • South Africa
    • Rest of MEA

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4839

Read More Reports:

Tapentadol (Palexia) Market @ https://www.biospace.com/article/tapentadol-palexia-market-size-share-industry-growth-trend-business-opportunities-challenges-drivers-and-restraint-research-report-by-2027/

Research Antibodies Market @ https://www.biospace.com/article/research-antibodies-market-analysis-statistics-revenue-demand-and-trend-analysis-research-report-by-2027/

Pigmentation Disorders Market @ https://www.biospace.com/article/pigmentation-disorders-market-trends-revenue-key-players-growth-share-and-forecast-till-2026/

Peripheral Intravenous Catheters Market @ https://www.biospace.com/article/peripheral-intravenous-catheters-market-size-share-growth-analysis-trend-and-forecast-research-report-by-2028/

Pentazocine Market @ https://www.biospace.com/article/pentazocine-market-analysis-statistics-revenue-demand-and-trend-analysis-research-report-by-2027/

Frequently Asked Questions Answered in the Report:

  • What is the estimated revenue growth rate of the global Cancer and Tumor Profiling market over the forecast period?
  • What are the major factors driving the global market revenue growth?
  • Which are the leading manufacturers and suppliers in the global Cancer and Tumor Profiling market?
  • Which regional market is expected to lead in terms of revenue share in the global Cancer and Tumor Profiling market over the forecast years?
  • What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis of the market?

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.